SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-21-036535
Filing Date
2021-07-12
Accepted
2021-07-12 16:25:57
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1/A ea144113-s1a5_unicycivethera.htm S-1/A 1630241
2 CONSENT OF MAYER HOFFMAN MCCANN P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING F ea144113ex23-1_unicycive.htm EX-23.1 2429
3 GRAPHIC image_001.jpg GRAPHIC 11465
4 GRAPHIC image_002.jpg GRAPHIC 45192
5 GRAPHIC image_003.jpg GRAPHIC 111047
6 GRAPHIC image_004.jpg GRAPHIC 64679
7 GRAPHIC image_005.jpg GRAPHIC 146890
8 GRAPHIC image_006.jpg GRAPHIC 31421
9 GRAPHIC image_007.jpg GRAPHIC 25838
10 GRAPHIC image_009.jpg GRAPHIC 49390
11 GRAPHIC image_010.jpg GRAPHIC 66947
12 GRAPHIC image_011.jpg GRAPHIC 68014
13 GRAPHIC image_012.jpg GRAPHIC 51166
14 GRAPHIC image_013.jpg GRAPHIC 52744
15 GRAPHIC image_014.jpg GRAPHIC 145070
16 GRAPHIC image_015.jpg GRAPHIC 27670
17 GRAPHIC image_016.jpg GRAPHIC 74548
  Complete submission text file 0001213900-21-036535.txt   2974550
Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-256367 | Film No.: 211085786
SIC: 2834 Pharmaceutical Preparations